Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress
Go back to Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 200.59 +3.40 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $197.19 | 52 Week High | $333.65 | |||
| Open | $199.34 | 52 Week Low | $223.02 | |||
| Day High | $202.00 | P/E | 25.68 | |||
| Day Low | $198.83 | EPS | $7.81 | |||
| Volume | 109,892 | |||||

